The Mutation Analysis Laboratory Services 2012-2016 Master Indefinite Delivery/Indefinite Quantity (IDIQ) contract was established by the National Institutes of Health (NIH) Clinical Center to procure specialized genetic testing services. This contract addresses the need for external laboratory support to complement the Clinical Center's internal testing capabilities, specifically focusing on low-volume mutation analysis across a broad range of genes. The vehicle enables the NIH to efficiently acquire targeted genetic testing services through a pre-qualified pool of laboratory service providers, allowing for flexible task order issuance based on specific research and clinical requirements.
While specific task order details are not provided in the available documentation, the contract's structure suggests multiple prime contractors were likely awarded to support mutation analysis testing across various gene research domains. Task orders under this vehicle would typically range from small, specialized genetic investigations to more comprehensive mutation screening projects. The contract's duration from November 2011 to March 2018 indicates a multi-year approach to procuring these critical laboratory services. Given the NIH's mission, task orders would predominantly support biomedical research, clinical investigations, and potentially rare disease studies requiring advanced genetic mutation analysis. The contract's design as a Master IDIQ allows for rapid, targeted procurement of mutation analysis services without requiring full and open competitive solicitation for each individual testing need.